chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting 06/28/2022, I had a headache, nasal congestion, sore throat, fatigue, chills, my jaw hurt and my ears hurt, and I felt like I had a sinus infection. I called my doctor on 06/29/2022 and they told me to take a COVID-19 test before coming in. I took the At-Home COVID-19 test which was positive. I called her back and asked if I could get Paxlovid. After having a telehealth visit, she called in a prescription for the Paxlovid. I was not able to get the Paxlovid until 06/30/2022 due to the local pharmacy not being able to dispense it.  Before starting it, I slept a lot and experienced all the symptoms that were noted above plus occasional chills, fever and my chest felt heavy. I did lose my sense of taste and smell, and I lost weight due to not being hungry. After starting the Paxlovid, within 2 days, I started feeling so much better. By that Sunday, 07/03/2022, I felt almost 100% better.
headache at 11pm night of the vaccine, 12-3am started having chills. Severe headache for the entire day following vaccine, and mild fever 99.8-100.2 at 6pm.
Difficult time trying to focus; Low energy; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 56-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration to left arm on 17Mar2021 at 13:30 (at the age of 56-year-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 07:00, the patient experienced extreme headache, very low energy and he had a difficult time trying to focus currently (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the adverse events. The clinical outcome of extreme headache, very low energy and difficult time trying to focus were not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information expected.
My son had severe eye swelling after his first shot. They swelled shut and we gave him adult benadryl every 6 hours for 24 hours.
2/4 At 4 am morning after receiving 2 does left arm sore to move. By 5:45 am total body aches by 7 am fever up to 101. Fatigue. And headaches began. 2/5, arm still sore, body aches, headache, and fatigue continue. 2/6 headache and body aches continue.
Pt received AFLURIA vaccine approximately 610pm 11/12/13 approx 730 pm (11/12/13) pt experienced shortness of breath, watering eyes, wheezing. Symptoms/signs worsened by 9 pm 11/12/13. Pt self administered dose of albuterol MDI at 9 pm. By 9 am, 11/13/13 s and sx were starting to clear. Pt took a 25 mg dose of diphenhydramine at 10 am s and sx gone by 6 pm 11/13/13.
Pfizer-BioNTECH Covid 19 vaccine EUA , side effect was a stroke affecting loss of vision in both eyes
BLOOD PRESSURE INCREASED; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 72 year old male. The patient's height, and weight were not reported. The patient's past medical history included death of wife, and concurrent conditions included high blood pressure, stress, and anxiety.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: 13-JUN-2021) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 01-APR-2021, the subject experienced injection site pain. On 09-APR-2021, the subject experienced blood pressure increased. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site pain on 05-APR-2021, and had not recovered from blood pressure increased. This report was non-serious.
She had a lot of pressure in her upper abdomen - like there was no room for her innards. Bloating. And then she vomited after experiencing this pressure - this was at 05:00 am before she had eaten. I talked to the nurse and I took her to Urgent Care - he did an EKG - he thought she needed to go to ED - for a CT scan - to find out about blockage in GI  - they did a CT scan and saw there was an obstruction in her small bowel. Emptied her stomach and put in a new GI tube. They admitted her to make sure it had resolved. She was in the hospital for about a week. They gave her treatment for anemia. The obstructions was constipation and she didn't know that because she had already been using Citricel daily and she thought she was having bowel movements daily. She had a hiatal hernia - it had been there for yours; small bowel obstruction - could have been from scars and adhesions from prior surgeries. It resolved in that week. She uses Miralax daily and Citrucel  - daily for bowel movement and they have her on Omeprazole - they think there might be something bleeding with lesions on her hernia.
The day after receiving the second dose patient had severe migraine, fever, and loss of vision. She was hospitalized for three days. She was diagnosed with Vogt-Koyanagi-Harada Disease. Patient has permanent autoimmune disease. She suffers from headaches, eye pain, dizziness, difficulty walking, muscle weakness, hearing loss, hair loss, vertigo, arthritis throughout entire body, both optic nerves detached from retinas, cognitive impairment, bruise easily, cataracts, loss of vision 20 over 200, weight loss, uveitis, severe pain all over body, severe depression, mood swings. She now has to live in a facility where 24 hour emergency staff can be called to assist if needed.
This case was reported by a physician and described the occurrence of vaginal yeast infection in a 17-year-old female subject who was vaccinated with HAVRIX 1440 (GlaxoSmithKline).  Concurrent medical conditions included borderline diabetes and gastroesoephageal reflux disease.  Concurrent vaccination given on 12 June 2008 included SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE vaccine; Sanofi.  Concurrent medications included PREVACID.  On 12 June 2008 at 16:30, the subject received 1st dose of HAVRIX 1440 elisa units (unknown, right arm).  A physician reported stated that he decided to give the subject an adult dose of HAVRIX, as she presented to his office one month prior to her 18th birthday.  On 13 June 2008, one day after vaccination with HAVRIX 1440, the subject's mother contacted the physician and stated that her daughter had developed a vaginal infection.  The subject was taken to her primary care physician, where she was diagnosed with a yeast infection and started on DIFLUCAN therapy.  At the time of reporting, the events were improved.  The physician considered the events were unrelated to vaccination with HAVRIX 1440.
This spontaneous report as received from a pharmacist refers to a 67 year old female patient. The patient did not have any concurrent conditions, concomitant therapies, medical history, known drug reactions or allergies. On 21-FEB-2016, the patient was vaccinated with a dose of ZOSTAVAX lot # reported as L039096, expiration date 08-JAN-2017 (dose and route of administration were not reported). On 22-FEB02916, the patient developed a 3 inch by 2 inch rash at the injection site. The patient sought medical attention by called the pharmacist. The outcome of the rash at the injection site and the relatedness between the event and ZOSTAVAX were not reported. Additional information is not expected as there was no consent for follow up.
Automobile Versus Pedestrian     Pt arrived to ED via EMS, activated as a level II trauma, Pt hit by car while crossing the street. est 45 mph. -Thinners/+LOC.      HPI  Patient is a 28-year-old male with past medical history of schizophrenia presenting after being pedestrian struck by a vehicle. He was reportedly crossing Road when a vehicle driving approximately 40-50 miles per hour struck him on on the left side of his body, causing him to fall to his right side. He states he did lose consciousness. There is evidence of head injury. Patient is currently complaining of right hip pain. No complaints otherwise.
This medically confirmed report (initial receipt 09-Jan-2014) concerns a 55-year-old male patient. On 04-Oct-2013, the patient received an unspecified influenza virus vaccine (manufacturer and batch number not reported) in his right arm. On unspecified dates, within a couple of weeks after vaccination, the patient developed ongoing right-sided hip pain, right leg pain which affected his walking and right foot not wanting to work. He stated that the pain was constant, but sometimes worsened. On 08-Jan-2014, the patient was able to go for a jog and the pain increased thereafter. The patient also reported that sometime after the vaccine was administered, he developed rash on his buttocks which had resolved. The patient went to the emergency room where lab work was done but no MRI (magnetic resonance imaging) /CAT scan (computed tomography) /X-ray were performed. The patient was not admitted to the hospital. He had a follow-up appointment on 10-Jan-2014. The patient saw the physician for the first time and the patient stated to physician that he thought he had nerve damage. Outcome was reported as not yet recovered. Follow up (10-Jan-2014) Medical confirmation, additional events and details.
Diarrhea, vomiting, headache, felt cold but did not check for a fever.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 09-JUN-2016, the patient was vaccinated with an expired dose of VARIVAX (lot # K007981, expiration date 03-JUN-2016, exact dose and route of administration were not reported). No adverse effect was reported. Additional information has been requested.
Patient blacked out roughly 1 minute after standing up post vaccines being given. Pt was caught and lowered to the floor without injury. BP was monitored and ammonia administered under the nose. Within 4-5 seconds patient returned to consciousness, stated he didn't know what happened. Pt was alert and oriented, was finally able to sit up in a chair while BP continued to be monitored. After 20 minutes or so- patient was walked to this lobby where wife was explained what happened and patient was able to leave under the supervision of his wife.
It began as the typical drowsiness and fussiness after shots. This lasted 2 days, then he started getting low fevers of 99.8 or so, trouble falling and staying asleep, and was extremely fussy, to the point of being inconsolable. He had a couple episodes of vomiting and diarrhea. Total time lasted about 10 days, although, he has been more fussy and hasn't slept as well ever since. Also, his reflux that previously existed has become much worse and he is on medication for it now (Zantac).  During his vaccine reaction, we called the doctor's office several times to talk to the advice nurse. They told us the vaccine reaction should only last a couple of days, and so when he became more and more inconsolable we took him into ER, not knowing what was wrong. They told us it was probably a vaccine reaction. Later in the week we took him to the doctor's office as he was still not recovering. He finally got better after 10 days. Again, he still does not seem quite as happy of a baby since then, his stomach seems more touchy and his reflux is worse.
5cm x 5cm red, swollen are at shot site.  Suspect allergic reaction.  Doubt cellulitis.
FEVER 103,TREMORS,WEAKNESS,FATIGUE,MACULAR RASH ON FACE,RASH AT VACCINE SITE ON LEFT DELTOID BEING OBLONG,ECCENTRICALLY LOCATED FROM THE INJECTION SITE-MEASURING 4CM X 4CM
Headache & NauseaVomiting  Narrative: employee states: by 5pm on 1/11/2021 she noticed a headache (not as severe as a migraine but stronger than a regular headache) She experienced nausea and arm soreness. She took ibuprofen 800mg last night and again this morning. Her head still hurts and she still has nausea and now is experiencing her "equilibrium off"
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On 19-FEB-2018, the patient was vaccinated with improperly stored  GARDASIL 9 (dosing details were not reported) (lot # N020353, expiry date: 28-APR-2020) for prophylaxis (product storage error). The vaccine was stored at a temperature of 47 degree fahrenheit to 77 degree fahrenheit (59.6 degree fahrenheit) for a time frame of 8 hours. No adverse effects reported. Previous temperature excursions was reported as "yes". There was a digital data logger involved. No product quality complaint involved. This is one of the several reports received from same reporter. Sender's Comments: US-009507513-1804USA004718.
Shortly after receiving vaccine left arm became itchy, burning, painful, and extremely swollen - went to ER & was admitted & kept for 2 days then transferred to larger hospital (infectious disease) for 4 more days.
Redness and soreness around injection site, rash on upper arm around injection site (small red bumps)
Next day after shot baseball size swelling at injection site. Swelling lasted 4-5 days. No fever July noticed swelling by outer right knee. Didn?t remember bumping. Swelling slowly moved across leg over thigh.  Bruising and swelling in vein. Went to ER
LIGHT HEADEDNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry date: Unknown) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 13-MAR-2021, the subject experienced light headedness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from light headedness. This report was non-serious. This case, from the same reporter is linked to 20210354458.
This spontaneous report as received from a nurse practitioner refers to a 3 months old male patient. The reporter reported that a patient received PNEUMOVAX 23 (lot # was unknown) as a first dose at 3 months of age in October 2011 and as a second dose at 4 months of age, in November 2011 for vaccination. The error was just recently discovered (date of discovery unspecified) and the patient was now 15 months of age. No product confusion discovered, No adverse event reported. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Little ache), SINUSITIS (Sinuses started burning and hot), NAUSEA (Some nausea (continuing a little)) and FATIGUE (Tired) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced SINUSITIS (Sinuses started burning and hot). On an unknown date, the patient experienced PAIN (Little ache), NAUSEA (Some nausea (continuing a little)) and FATIGUE (Tired). At the time of the report, PAIN (Little ache), SINUSITIS (Sinuses started burning and hot), NAUSEA (Some nausea (continuing a little)) and FATIGUE (Tired) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication information is not provided. Treatment medication information is not provided. On 01-mar-2021 patient visited a dentist after which sinuses started burning and hot.  The patient is due for the  second dose tomorrow 11Mar2021.
This spontaneous report as received from a health professional refers to an unspecified number of patient of unknown demographics. The concomitant medications, medical history and concomitant medications were unknown. On an unknown date in 2016 (reported as on or after 24-MAR-2016) the patients were vaccinated with unspecified number of improperly stored doses of ROTATED. The vaccine was stored at 47 F for 72 hours. There were no previous excursions. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
neuropathy; loss of balance; This case was reported by a pharmacist via call center representative and described the occurrence of neuropathy in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number MT7C9, expiry date unknown) for prophylaxis.   Concurrent medical conditions included low back pain.   On 31st May 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced neuropathy (serious criteria GSK medically significant) and loss of balance. On an unknown date, the outcome of the neuropathy and loss of balance were not recovered/not resolved.   It was unknown if the reporter considered the neuropathy and loss of balance to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm. After receiving Shingrix, the patient experienced loss of balance and neuropathy. The patient received some treatment for lower back pain in March 2020 and the patient did not know if the adverse events reported started after the lower back pain treatment. The reporter was consented to follow up.
colds; Flu; This is a spontaneous report from a Pfizer sponsored program COVAX US Support. A contactable male consumer reporting for himself that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 24Apr2021 (Batch/Lot number was not reported) as 1st dose, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced colds and flu in 2021. The outcome of the events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Starting when I woke up this morning, I had what I'd call mild hearing loss.  It varied, moving back and forth between the two ears, throughout the day.  It is now 1:30 and is a little better but still there.
Pt was transferred from living center (LC) to ED and then to ICU 4 days after he received a flu shot. He was noted to be lethargic, nail beds and lips were blue, respirations labored, BS 321, B/P 98/58, P 82, T 96.8, R 22. He was transferred to general medicine floor the next day and then back to LC 2 days later. The LC physician reported that the flu shot has caused him to be admitted to the hospital the last 3 years d/t hypotension, etc. Nausea, vomiting and hypotension. Sodium chloride.
patient waited about 15 minutes after his vaccine. Upon leaving patient began to feel light headed. patient was then asked to take a seat and vitals were check. patient showed hypertension (which he states was due to not taking his blood pressure medications x 3 days) and patient also showed mild tachycardia (102BPM), patient states increased heart rate is due to his anxiety. Other vitals stable. patient was then monitored for an additional 10 minutes and states he is no longer light headed. patient is given advice to follow up with his doctor about his high blood pressure and encouraged to call 911 if he experiences any symptoms after leaving.
Pt. had warm, erythemous, indurated, pruritic area 7cm around the injection site on left thigh.
marked swelling; Marked edness; Axillary pain; This case was reported by a nurse via sales rep and described the occurrence of local swelling in a patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced local swelling, localized erythema and axillary pain. On an unknown date, the outcome of the local swelling, localized erythema and axillary pain were unknown.   It was unknown if the reporter considered the local swelling, localized erythema and axillary pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-SEP-2022 Reporter's Comment: The patient received the first dose of Bexsero vaccine recently. The patient had a large local reaction. The patient experienced marked swelling and redness and axillary pain.
Eczema got inflamed, rashes appeared on both forearms days 2 to 4. Rashes appeared on back days 4 to 7. Rashes appeared on shoulders and legs days 5 to 7. Rashes are continuing on shoulders, leg, and back.
Per patient's she has a history of feeling dizzy after vaccination (one time for a flu shot). Approximately, 5 minutes after vaccinating the patient, patient came up to the counter stating that she is dizzy and feel to the floor. We quickly went to check on the patient and patient stated she is feeling very dizzy. When asked if she can breath, she stated she is fine and the only thing is dizziness, which happened before. Patient was extremely weak and pharmacy staff helped her into the immunization room to sit and lay her head down. We got her some juice and chips, which helped the patient. Patient was resting for about 20 minutes in the immunization with another pharmacy staff. Patient was advised to report any other symptoms that may require us to call the ambulance. After about 20 minutes, pt came out of the room and sat for about 10-15 more minutes again. When asked the patient how she is feeling again, she said she is feeling normal again and that it had only happened to her once. Patient left the pharmacy in good condition.
Chills; Aching over whole body; Covid-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and COVID-19 (Covid-19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for an unknown indication.     No medical history was provided by the reporter.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced COVID-19 (Covid-19). On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) and COVID-19 (Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.